PTK2 and breast cancer: Studies to establish MMP-9 expression, downstream of FAK protein activation and β-catenin stabilization (by performing FAK knockout and luciferase promoter reporter chromatin immunoprecipitation assays) in breast cancer cells, would also elucidate these relationships.